Table 4.
Baseline questionnaire measures
| Outcome | Exercise group | Usual care |
|---|---|---|
| Mean ± SD | Mean ± SD | |
| Quality of life | ||
| EQ-5D Index Score | 0.9 ± 0.1 | 0.8 ± 0.2 |
| ED-5D VAS | 82 ± 13 | 78 ± 14 |
| FACT-P | ||
| Physical WB | 25.4 ± 1.8 | 24.3 ± 2.9 |
| Social WB | 23.4 ± 3.5 | 22.5 ± 3.6 |
| Emotional WB | 21.6 ± 2.4 | 20.8 ± 3.7 |
| Functional WB | 21.5 ± 5.2 | 21.2 ± 5.5 |
| Prostate cancer specific | 34.5 ± 3.2 | 33.3 ± 5.2 |
| FACT-P TOI | 81.4 ± 8.7 | 78.8 ± 11.5 |
| FACT-P Total Score | 126.4 ± 12.1 | 122.2 ± 16.2 |
| FACT-G Total Score | 91.9 ± 10.0 | 88.8 ± 12.1 |
| Fatigue | ||
| BFI | 1.2 ± 1.2 | 1.9 ± 1.4 |
| Godin Leisure Time Exercise Questionnaire (modified) | ||
| VA frequency (days/week) | 0.0 ± 0.0 | 0.4 ± 1.5 |
| VA duration (mins/session) | 0.0 ± 0.0 | 1.1 ± 3.8 |
| MIA frequency (days/week) | 1.8 ± 2.8 | 1.1 ± 2.0 |
| MIA duration (mins/session) | 15.9 ± 27.6 | 25.7 ± 56.5 |
| LIA frequency (days/week) | 4.6 ± 2.2 | 5.3 ± 2.6 |
| LIA duration (mins/session) | 40.0 ± 31.5 | 59.6 ± 61.4 |
| RET frequency (days/week) | 0.4 ± 1.6 | 0.5 ± 1.6 |
| RET duration (mins/session) | 0.5 ± 2.2 | 2.5 ± 9.7 |
SD standard deviation, VAS visual analogue scale, WB well-being, TOI trial outcome index, VA vigorous aerobic activity, MIA moderate intensity aerobic activity, LIA low-intensity aerobic activity, RET resistance exercise training